Telemetry for cardiovascular monitoring in a pharmacological study: New approaches to data analysis

Hypertension

Volumn 33, Issue 1 II, 1999, Pages 248-255

  Anderson, Niall H ^a,c   Devlin, Alison M ^a   Graham, Delyth ^a   Morton, James J ^a   Hamilton, Carlene A ^a   Reid, John L ^a   Schork, Nicholas J ^b   Dominiczak, Anna F ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WESTERN INFIRMARY   (United Kingdom)

Author keywords

Hypertension, genetic; Hypertrophy, cardiac; Rats; Statistics; Telemetry

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; HYDROCHLOROTHIAZIDE; LOSARTAN; N(G) NITROARGININE METHYL ESTER; PERINDOPRIL; THIAZIDE DIURETIC AGENT; VASODILATOR AGENT;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; HEMODYNAMIC MONITORING; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; TELEMETRY; VASCULAR SMOOTH MUSCLE;

EID: 0032942661     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.33.1.248     Document Type: Article

References (32)

1. Bunag RD. Facts and fallacies about measuring blood pressure in rats. Clin Exp Hypertens [A]. 1983;5:1659-1681.
2. Davidson AO, Schork N, Jaques BC, Sutcliffe RG, Kelman AW, Reid JL, Dominiczak AF. Blood pressure in genetically hypertensive rats: influence of the Y chromosome. Hypertension. 1995;26:452-459.
3. Kren V, Pravenec M, Lu S, Krenova D, Wang J-M, Wang N, Merriouns T, Wong A, St Lezin E, Lau D, Szpirer C, Szpirer J, Kurtz TW. Genetic isolation of a region of chromosome 8 that exerts major effects on blood pressure and cardiac mass in the spontaneously hypertensive rat. J Clin Invest. 1997;99:577-581.
4. Smith TL, Hutchins PM. Anesthetic effects on hemodynamics of spontaneously hypertensive and Wistar-Kyoto rats. Am J Physiol. 1980; 238(Heart Circ Physiol):H539-H544.
5. Evans AL, Brown W, Kenyon CJ, Maxted KJ, Smith DC. Improved system for measuring systolic blood pressure in the conscious rat. Med Biol Eng Comput. 1994;32:101-102.
6. Kvetnansky R, Sun CL, Torda T, Kopin IJ. Plasma epinephrine and norepinephrine in stressed rats: effect of adrenalectomy. Pharmacologist. 1977;19:241-247.
7. Brockway BP, Mills PA, Azar SH. A new method for continuous chronic measurement and recording of blood pressure, heart rate, and activity in the rat via radio-telemetry. Clin Exper Hypertens [A]. 1991;13:885-895.
8. Clark JS, Jeffs B, Davidson AO, Lee WK, Anderson NH, Bihoreau M-T, Brosnan MJ, Devlin AM, Kelman AW, Lindpaintner K, Dominiczak AF. Quantitative trait loci in genetically hypertensive rats: possible sex specificity. Hypertension. 1996;28:898-906.
9. van den Buuse M. Circadian rhythms of blood pressure, heart rate, and locomotor activity in spontaneously hypertensive rats as measured with radio-telemetry. Physiol Behaviour. 1994;55:783-787.
10. Bohlender J, Ménard J, Luft FC, Ganten D. Dose effects of human renin in rats transgenic for human angiotensinogen. Hypertension. 1997;29: 1031-1038.
11. Lemmer B, Mattes A, Böhm M, Ganten D. Circadian blood pressure variation in transgenic hypertensive rats. Hypertension. 1993;22:97-101.
12. Parati G, Saul JP, Di Rienzo M, Mancia G. Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation: a critical appraisal. Hypertension. 1995;25:1276-1286.
13. Devlin AM, Gordon JF, Davidson AO, Clark JS, Hamilton CA, Morton JJ, Campbell AM, Reid JL, Dominiczak AF. The effects of perindopril on vascular smooth muscle polyploidy in stroke-prone spontaneously hypertensive rats. J Hypertens. 1995;13:211-218.
14. Dominiczak AF, Devlin AM, Lee WK, Anderson NH, Bohr DF, Reid JL. Vascular smooth muscle polyploidy and cardiac hypertrophy in genetic hypertension. Hypertension. 1996;27:752-759.
15. Devlin AM, Davidson AO, Gordon JF, Campbell AM, Morton JJ, Reid JL, Dominiczak AF. Vascular smooth muscle polyploidy in genetic hypertension: the role of angiotensin II. J Human Hypertens. 1995;9: 497-500.
16. Devlin AM, Brosnan MJ, Graham D, Morton JJ, McPhaden AR, McIntyre M, Hamilton CA, Reid JL, Dominiczak AF. Vascular smooth muscle cell polyploidy and cardiomyocyte hypertrophy due to chronic NOS inhibition in vivo. Am J Physiol. 1998;274:(Heart Circ Physiol): H52-H59.
17. Vindelov LL, Christensen IJ, Nissen NI. A detergent trypsin method of preparation of nuclei for flow cytometric DNA analysis. Cytometry. 1983;3:323-327.
18. Cleveland RB, Cleveland WS, Macrae JE, Terpening I. STL: a seasonal-trend decomposition procedure based on Loess. J Official Statistics. 1990;6:3-73.
19. Cleveland WS, Devlin SJ. Locally-weighted regression: an approach to regression analysis by local fitting. J Am Statistical Assoc. 1988;83: 596-610.
20. Calhoun DA, Zhu S, Wyss JM, Oparil S. Diurnal blood pressure variation and dietary salt in spontaneously hypertensive rats. Hypertension. 1994; 24:1-7.
21. Black MJ, Bertram JF, Campbell JH, Campbell GR. Angiotensin II induces cardiovascular hypertrophy in perindopril-treated rats. J Hypertens. 1995;13:683-692.
22. Owens GK. Differential effects of antihypertensive drug therapy on vascular smooth muscle cell hypertrophy and hyperplasia in the spontaneously hypertensive rat. Circ Res. 1985;56:526-536.
23. Frattola A, Parati G, Cuspid C, Albini F, Mancia G. Prognostic value of 24-hour blood pressure variability. J Hypertens. 1993;11:1133-1137.
24. Oddie CJ, Dilley RJ, Kanellakis P, Bobik A. Chronic angiotensin II type 1 receptor antagonism in genetic hypertension: effects on vascular structure and reactivity. J Hypertens. 1993;11:717-724.
25. Takemoto M, Egashira K, Tomita H, Usui M, Okamoto H, Kitabatake A, Shimokawa H, Sueishi K, Takeshita A. Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis. Hypertension. 1997;30:1621-1627.
26. Takemoto M, Egashira K, Usui M, Numaguchi K, Tomita H, Tsutsui H, Shimokawa H, Sueishi K, Takeshita A. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats. J Clin Invest. 1997;99:278-287.
27. G-nitro-L-arginine methyl ester due to converting enzyme inhibition. J Cardiovasc Pharmacol. 1996;28:142-148.
28. 1 receptor mechanism in rat aorta. FASEB J. 1994;8:A367. Abstract 2124.
29. Seyedi N, Xu XB, Nasjiletti A, Hintze TH. Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation. Hypertension. 1995;26:164-170.
30. 2 receptor stimulation increases aortic cGMP in SHRSP by a kinin-dependent mechanism. Hypertension. 1998; 31:349-355.
31. Pollman MJ, Yamada T, Horiuchi M, Gibbons GH. Vasoactive substances regulate vascular smooth muscle cell apoptosis: countervailing influences of nitric oxide and angiotensin II. Circ Res. 1996;79:748-756.
32. Ichiki T, Usui M, Kato M, Funakoshi Y, Ito K, Egashira K, Takeshita A. Down-regulation of angiotensin II type 1 receptor gene transcription by nitric oxide. Hypertension. 1998;31:342-348.